Franklin Genomic Advancements ETF (HELX)

Cboe BZX: HELXExchange-traded fund from Franklin Templeton, Inc.

  • Expense ratio0.50%
  • Net assets$34.2M
  • Dividend yield0.32%
  • 1-year return+28.08%
  • Holdings65

HELX ETF price chart

HELX quote & trading statistics

  • YTD+17.30%
  • 1 year+28.08%
  • 3 years+17.39%/yr
  • 5 years-3.89%/yr
  • 10 years0.00%/yr
1Y volatility
23.19%
3Y volatility
22.03%
3Y Sharpe ratio
0.60

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

HELX top 10 holdings

All holdings →
Franklin Genomic Advancements ETF largest holdings by weight
#SymbolNameWeight
1NTRANatera Inc10.59%
2GHGuardant Health Inc9.22%
3KRYSKrystal Biotech Inc4.81%
4ADPTAdaptive Biotechnologies Corp4.49%
5LGNDLigand Pharmaceuticals Incorporated4.37%
6TWSTTwist Bioscience Corp3.99%
7MEDPMedpace Holdings Inc2.96%
8BBIOBridgeBio Pharma Inc2.91%
9UTHRUnited Therapeutics Corporation2.72%
10VRTXVertex Pharmaceuticals Inc2.70%

The top 10 holdings make up 48.8% of the fund (65 holdings in total). As of October 24, 2026.

HELX sector weights

Healthcare
94.3%
Financial Services
2.1%
Technology
0.7%
Basic Materials
0.4%

HELX region weights

North America
98.3%
Europe Developed
2.4%
Asia Developed
1.1%
United Kingdom
1.0%

HELX asset allocation

U.S. stocks
95.6%
Non-U.S. stocks
4.3%
Cash
0.1%

HELX market-cap breakdown

Small cap
43.0%
Mid cap
34.9%
Micro cap
8.4%
Large cap
5.9%
Mega cap
4.2%

About Franklin Genomic Advancements ETF

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

HELX ETF FAQ

What is the HELX expense ratio?

Franklin Genomic Advancements ETF has a net expense ratio of 0.50%, or $50.00 a year for every $10,000 invested.

How much money is in HELX?

Franklin Genomic Advancements ETF has about $34.2M in net assets.

What are the top holdings of HELX?

The largest positions in HELX are Natera Inc (10.59%), Guardant Health Inc (9.22%), Krystal Biotech Inc (4.81%). The fund holds 65 securities in total.

How has HELX performed?

HELX returned +28.08% over the past year and -3.89% a year over the past five years, including reinvested distributions.

Does HELX pay dividends?

HELX has a dividend yield of 0.32%.

When was HELX launched?

Franklin Genomic Advancements ETF began trading on February 25, 2020.